WEBULL
WebtradeDownload

Is Centene (CNC) Undervalued As Medicaid Margin Recovery Comes Into Focus?

Simply Wall St · 2d ago

Conference spotlight and recent performance

Centene (CNC) heads into its Deutsche Bank 2026 Healthcare Summit presentation on September 16 with the stock recently closing at US$67.10 after gains over the past month and the past 3 months.

The recent 1-day share price return of 1.65% and 90-day share price return of 9.96% point to building momentum for Centene, while the 1-year total shareholder return of 108.58% contrasts with a slightly negative 3-year total shareholder return, indicating a sharp rebound after a tougher period.

Scan beyond Centene and spot other healthcare stocks with similar momentum and fundamentals by reviewing the curated 29 high quality undervalued stocks today.

Centene has delivered a sharp rebound and carries a strong business profile in Medicaid, Medicare and commercial plans. After this kind of move, the real test is simple: Do the current numbers justify today’s price?

Most Popular Narrative: 6% Undervalued

On the most followed narrative, Centene’s fair value of $71.67 sits modestly above the recent $67.10 close. This puts investor focus squarely on whether margin repair and revenue mix can support that gap.

Centene's Medicaid business is expected to see margin recovery as rate adjustments align better with member acuity, which could improve Medicaid-related revenue and net margins. Overall strength and competitiveness in winning Medicaid contracts, such as the fully integrated D-SNP in Illinois and Medicaid expansion into rural Nevada, may drive future revenue growth and market share.

See why 56 investors see Centene as 6% undervalued.

Result: Fair Value of $71.67 (UNDERVALUED)

Still, the Centene story can change quickly if Medicaid rate decisions disappoint, or if medical costs such as flu and specialty drugs spike again.

Find out about the key risks to this Centene narrative.

Next Steps

Mixed signals in the Centene story. Act while the conference spotlight is hot and review both the concerns and the upside in the 3 key rewards and 1 important warning sign.

Looking for more Centene-sized investment ideas?

Centene is only one way to put capital to work. If you stop here, you could miss other opportunities that fit your goals just as well.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.